We are live on !
Find out more
Crestline Management Portfolio holdings
AUM
$29.3M
Turnover
33.33%
1-Year Est. Return
36.29%
This Fund
S&P 500
This Quarter Est. Return
+25.68%
1 Year Est. Return
+36.29%
3 Year Est. Return
+56.08%
5 Year Est. Return
+35.53%
10 Year Est. Return
+400.77%
AUM
$746M
AUM Growth
+$200M
(+37%)
Cap. Flow
+$60.7M
Cap. Flow % of AUM
Cap. Flow %
8.13%
Top 10 Holdings %
Top 10 Hldgs %
76.52%
Holding
190
New
78
Increased
30
Reduced
20
Closed
61
Avg Time Held
Equity + Options
0.2
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto
MON
|
+$6.18M |
| 2 |
Verisk Analytics
VRSK
|
+$5.61M |
| 3 |
Air Products & Chemicals
APD
|
+$4.62M |
| 4 |
Dun & Bradstreet
DNB
|
+$4.57M |
| 5 |
Honeywell
HON
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNB
FNB
|
+$5.19M |
| 2 |
Dover
DOV
|
+$4.9M |
| 3 |
Associated Banc-Corp
ASB
|
+$3.9M |
| 4 |
KeyCorp
KEY
|
+$3.73M |
| 5 |
PACW
PacWest Bancorp
PACW
|
+$2.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.39% |
| 2 | Financials | 12.59% |
| 3 | Industrials | 5.43% |
| 4 | Materials | 3.1% |
| 5 | Technology | 1.1% |
Similar funds
BAS
MP
VL
Crestline Management's Q2 2017 Portfolio in Review
As of Q2 2017, Crestline Management held 190 positions worth $746M, up 37% from $546M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Crestline Management deployed $60.7M of net new capital in Q2 2017, opening 78 new positions and adding to 30 existing holdings. Its largest new stake was Monsanto: 53,000 shares worth $6.27M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 75% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was FNB, an estimated $5.19M trimmed.
- Crestline Management's largest Q2 2017 buy was Monsanto: 53,000 shares worth $6.27M.
- Crestline Management added most to Honeywell in Q2 2017, an estimated $4.05M increase.
- Crestline Management's biggest Q2 2017 reduction was FNB, cutting an estimated $5.19M.
- Crestline Management fully exited Dover in Q2 2017, selling an estimated $4.9M.
- Crestline Management's ten largest holdings make up 77% of its $746M portfolio in Q2 2017.
- Crestline Management opened 78 new positions and closed 61 in Q2 2017.
- Crestline Management's portfolio value rose 37% quarter-over-quarter to $746M.
Based on Crestline Management's 13F filing for Q2 2017, filed 14 Aug 2017.